Information is constantly being added to this site. Please check back again soon, for additional event details.

Presentation Theaters

Presentations hosted by exhibitors and/or non-exhibitors in two Presentation Theaters located in the exhibit hall during exhibit hours. Companies will showcase new products and/or treatment options during the Annual Convention and Scientific Assembly. Presentation theaters will feature non-CME presentations/speakers with food and beverage in each theater.

Monday, August 5th

PrEP today. Data discussions on an HIV-1 PrEP option

Theater #1 | 11:30 AM – 12:30 PM

During this educational session, attendees will learn about an alternative PrEP option to help prevent HIV in their patients. The program will review important information, clinical data, and dosing and administration, and provide guidance on identifying patients who would benefit. In addition, the program will also feature a Patient Ambassador who will share their personal experience with this PrEP option and discuss how it impacted their life.


  • Toyin Nwafor, M.D. | Moderator
  • Marcus Sandling, M.D. | Callen-Lorde Community Health Center
  • Shae P | Patient Ambassador

Sponsored by: ViiV Healthcare


The Value of Screening with the Cologuard® Test in Black/African American Populations

Theater #2 | 11:30 AM – 12:30 PM

Why does colorectal cancer (CRC) remain the most preventable yet least prevented cancer in the US? A look at CRC screening gaps, the importance of support and multi-modality protocols that help address screening barriers in African Americans.


  • Travelle Ellis | Senior Director, Multicultural Initiatives

Sponsored by: Exact Sciences


Xolair: A Therapeutic Option for IgE-Mediated Food Allergies

Theater #1 | 1:00-2:00 PM

The presentation will be an on-label review of the efficacy and safety data which led to the approval of Xolair for Food Allergy.  It will also include Xolair “important safety information”, Xolair dosing and administration, Xolair patient support services, as well as information on food allergy prevalence, causes and current management options.


  • Purvi Parikh, M.D.

Sponsored by: Genetech – Xolair


Reestablishing the Fundamentals to Help Accelerate PrEP Uptake 

Theater #2 | 1:00-2:00 PM

  • Elevate the central role that healthcare providers can play in addressing HIV prevention needs
  • Address barriers to pre-exposure prophylaxis (PrEP) uptake and access while providing clarity around the affordability of PrEP
  • Emphasize the need for a systems change designed to increase the uptake of rapid PrEP initiation for those who could benefit from it


  • Leisha McKinley Beach, M.P.H. | Founder and CEO, Black Public Health Academy
  • Natalie L. Wilson, Ph.D., D.N.P., M.P.H., APRN-BC | Assistant Professor, Community Health Systems, School of Nursing, University of California, San Francisco
  • Byron Perkins | Former Hampton University, Student-Athlete, Philanthropist, Actor, Creative, and Influencer
  • Darryl Williams | Chief Content Officer, Almost Cake LLC
  • Michael G. Knight, M.D., MSHP | Clinical Associate Professor of Medicine, School of Medicine and Health Sciences, The George Washington University

Sponsored by: Gilead Sciences

Tuesday, August 6

Beneath the Surface of CKD in African Americans: APOL1-Mediated Kidney Disease (AMKD)

Theater #1 | 11:30 AM – 12:30 PM

APOL1-mediated kidney disease (AMKD) is a rapidly progressive and variably proteinuric kidney disease impacting people of African ancestry. The speakers will discuss the emerging role of genetics in precision kidney care and review unmet medical needs in a challenging patient journey with AMKD.


  • Margaret Collins, M.D. | Medical Director, Vertex Pharmaceuticals
  • Niva Lubin-Johnson, M.D. | Past President, National Medical Association; Clinical Consultant, Quality Primary Care PC

Sponsored by: Vertex Pharmaceuticals


Understanding MASH: Exploring the Role of Metabolic Dysfunction in an Often Silent and Progressive Liver Disease

Theater #2 | 11:30 AM – 12:30 PM

Join us as we discuss MASH (metabolic dysfunction-associated steatohepatitis) and the impact of the underlying metabolic dysfunction on disease

progression. We will also discuss the importance of early identification and screening for at-risk patients and review current management considerations.


  • Sonal Kumar, M.D., M.P.H. | Director, General Gastroenterology and Hepatology; Director, Innovative Center for Health and Nutrition in Gastroenterology (ICHANGE/GI Obesity Clinic); Assistant Professor of Medicine, Weill Cornell Medical College

Sponsored by: Novo Nordisk


Exploring Disease and Disparities for African Americans Living With Multiple Myeloma

Theater #1 | 1:00-2:00 PM

This program shines a spotlight on racial disparities in the diagnosis and outcomes of multiple myeloma. Those who attend this program can expect to gain insight into factors that may be responsible for these disparities and will be presented with several approaches that may help address them.


  • Brion Randolph, M.D. | University of Tennessee Health Science Center

Sponsored by: Bristol Myers Squibb


Reframing Rescue Therapy to Help Prevent Asthma

Theater #2 | 1:00-2:00 PM

Ready to uncover the unmet needs in asthma? Join us to discuss variable inflammation in the occurrence of asthma exacerbations and the consequent burden of repeated systemic corticosteroid exposures. Learn about patient preferences for asthma treatment and recommendations from GINA and NAEPP. Data on a rescue treatment option will be reviewed.


  • Autumn Burnette, M.D.; Howard University

Sponsored by: AstraZeneca

Stay Connected & Informed

Follow NMA on social media…